Guest guest Posted April 13, 2002 Report Share Posted April 13, 2002 But medicaid wouldn't pay for it would they.....? > try the Canadian pharmacy that was shown on abc news to get your Rx > filled… http://www.rxnorth.com/ > > sam Liz ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ EMAIL: juliette@... **ICQ 49746198** MSN & AIM LizKP1952** PERSONAL HOMEPAGE PAGE http://members.tripod.com/~LizK ADDult HOME PAGE: http://members.tripod.com/~LizK/addult.htm ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ " I'm just catching up with yesterday; by tomorrow I should be ready for today! " Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 14, 2002 Report Share Posted April 14, 2002 Hi liz.. I don’t know the dynamics of your American pharmacy regulations as to who pays for what...all I know is that the Americans are coming over all our borders in droves and using the internet to get their drugs because of the cost... You would have to ask your Medicaid provider I assume..sorry I cant be more helpful.. In Canada we get our drugs pretty well for free....or minimal cost Regards sam Re: enbrel remicade But medicaid wouldn't pay for it would they.....? > try the Canadian pharmacy that was shown on abc news to get your Rx > filled… http://www.rxnorth.com/ > > sam Liz ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ EMAIL: juliette@... **ICQ 49746198** MSN & AIM LizKP1952** PERSONAL HOMEPAGE PAGE http://members.tripod.com/~LizK ADDult HOME PAGE: http://members.tripod.com/~LizK/addult.htm ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ " I'm just catching up with yesterday; by tomorrow I should be ready for today! " ------------------------------------------------- Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 4, 2008 Report Share Posted June 4, 2008 June 5, 2008 F.D.A. Reviews Arthritis Drugs for Cancer Link By THE ASSOCIATED PRESS WASHINGTON — Federal regulators are investigating whether a group of arthritis drugs made by Abbott Laboratories, the Schering-Plough Corporation and other companies heighten the risk of cancer in youngsters. The Food and Drug Administration said Wednesday that it had received 30 reports of children and young adults developing cancer while taking the drugs over the last 10 years. The drugs include Abbott Labs' Humira, Schering-Plough's Remicade and Enbrel, which is marketed by Amgen and Wyeth. The drugs are prescribed to children with arthritis to block a chemical that causes inflammation. They are also used to treat children with the intestinal disorder Crohn's disease. Calls placed to the companies were not immediately returned Wednesday morning. The agency said the drugs' labeling already warns of a potential association with cancer, but the agency's investigation will focus on risks to younger patients. The agency has asked drug makers to provide all information about children who developed cancer while taking the medications. Regulators will report the findings of their review by November. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 4, 2008 Report Share Posted June 4, 2008 That is exactly why we are looking for an alternative to these medications!!!zahavi <zahavi100@...> wrote: June 5, 2008 F.D.A. Reviews Arthritis Drugs for Cancer Link By THE ASSOCIATED PRESS WASHINGTON — Federal regulators are investigating whether a group of arthritis drugs made by Abbott Laboratories, the Schering-Plough Corporation and other companies heighten the risk of cancer in youngsters. The Food and Drug Administration said Wednesday that it had received 30 reports of children and young adults developing cancer while taking the drugs over the last 10 years. The drugs include Abbott Labs' Humira, Schering-Plough's Remicade and Enbrel, which is marketed by Amgen and Wyeth. The drugs are prescribed to children with arthritis to block a chemical that causes inflammation. They are also used to treat children with the intestinal disorder Crohn's disease. Calls placed to the companies were not immediately returned Wednesday morning. The agency said the drugs' labeling already warns of a potential association with cancer, but the agency's investigation will focus on risks to younger patients. The agency has asked drug makers to provide all information about children who developed cancer while taking the medications. Regulators will report the findings of their review by November. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.